Loading…
Loading…
The British Business Bank (BBB) committed up to GBP 50 million as a cornerstone fund investor in IQ Capital Fund V, operated through British Patient Capital Limited, BBB's wholly-owned commercial subsidiary. IQ Capital (IQC), founded 2005 and based in London and Cambridge, is an early-stage deep tech VC firm that has backed over 250 deeptech founders from pre-seed through growth stage. Fund V continues IQC's early-stage venture strategy across five thematic areas: AI & Automation, Computing & Semiconductors, Health & Bio, Advanced Engineering & Energy, and Security & Resilience.
BBB has now made cornerstone commitments to all seven IQC funds (five flagship funds plus two growth-strategy funds), starting with Fund I in 2006, and has separately co-invested alongside IQC into four portfolio companies (Thought Machine, Paragraf, CyberSmart, Cambridge GaN Devices). IQC has grown to c. GBP 1bn AUM over the 20-year relationship. As with other BBB fund-of-funds commitments, the cornerstone stake is intended to help the fund reach a first close and signal confidence that mobilises additional private capital, consistent with the capital-crowding mandate under the UK's Modern Industrial Strategy ("Invest 2035", Command Paper CP 1451).
single-company stake; severity set at 1, consistent with prior BBB fund-commitment filings of similar scale (e.g. WestBridge III, SV8 Biotech Fund).
capital as a recurring BBB/British Patient Capital allocation target, distinct from regional-growth or biotech-specific vehicles.
commitment, classified "Red"); no export- or trade-control dimension is present.
attract inbound foreign investment-screening scrutiny (e.g. under the National Security and Investment Act) given the AI/compute and semiconductor thematic focus.
cadence through 2026 as part of its CP 1451 capital uplift.